Currently out of the existing stock ratings of Gabrielle Zhou, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).

Gabrielle Zhou

Work Performance Price Targets & Ratings Chart

Analyst Gabrielle Zhou, currently employed carries an average stock price target met ratio of 50% that have a potential upside of 12.43% achieved within 63 days. Previously, Gabrielle Zhou worked at MAXIM GROUP.

Gabrielle Zhou’s has documented 15 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BGNE, BeiGene Ltd at 28-Sep-2017.

Wall Street Analyst Gabrielle Zhou

Analyst best performing recommendations are on BGNE (BEIGENE LTD).
The best stock recommendation documented was for BGNE (BEIGENE LTD) at 6/30/2017. The price target of $52 was fulfilled within 3 days with a profit of $7 (15.56%) receiving and performance score of 51.85.

Average potential price target upside

BGNE BeiGene Ltd TEVA Teva Pharma Industries Ltd ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$300

$120.65 (67.27%)

$319

15 days ago
(03-Dec-2024)

3/10 (30%)

$93.22 (45.08%)

126

Buy

$260

$80.65 (44.97%)

$254

1 months 5 days ago
(13-Nov-2024)

4/8 (50%)

$61.6 (31.05%)

125

Buy

$288

$108.65 (60.58%)

$285

4 months 10 days ago
(08-Aug-2024)

0/4 (0%)

$104.97 (57.35%)

Hold

$164.3

$-15.05 (-8.39%)

$212

8 months 10 days ago
(08-Apr-2024)

3/3 (100%)

$14.55 (9.72%)

135

Buy

$345

$165.65 (92.36%)

$350

9 months 21 days ago
(27-Feb-2024)

2/5 (40%)

$165.31 (92.00%)

350

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Gabrielle Zhou?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?